BridgeBio Pharma, Inc. Insider Trading

BBIO

Last 12 months

Insiders sold $105M and bought nothing on the open market.

89% of the selling was scheduled in advance under 10b5-1 plans. Director Andrew Lo sold $6.32M on Nov 18, 2025, 60% of their stake, outside a plan. The last open-market buy by an executive or director was in Mar 2022.

Net open-market

−$105M

0 buys · 37 sales

Under a 10b5-1 plan

89%

of the value sold

Insiders who bought / sold

0 / 9

executives and directors

Last open-market buy

Mar 2022

Mar 15, 2022

Get an email when BBIO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 30	Maricel Apuli Chief Accounting Officer	Sold10b5-1 plan	2,000	$72.85	146K	1.6%	Form 4
Sep 17	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 2 parts	10,000	$69.08 average	691K	0.2%	Form 4
Aug 18 – 19	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 7 parts	44,980	$82.86 average	$3.73M	0.9%	Form 4
Jul 30	Maricel Apuli Chief Accounting Officer	Sold10b5-1 plan	2,000	$80.06	160K	1.5%	Form 4
Jul 9	Andrea Ellis Director	Sold10b5-1 plan	17,167	$84.00	$1.44M	43%	Form 4
Jul 9	Jennifer E. Cook Director	Sold10b5-1 plan 2 parts	148,589	$88.54 average	$13.2M	95%	Form 4
Jun 23 – 24	Jennifer E. Cook Director	Sold10b5-1 plan 2 parts	39,363	$69.92 average	$2.75M	82%	Form 4
Jun 22 – 23	Hannah Valantine Director	Sold10b5-1 plan 2 parts	5,004	$68.25 average	342K	34%	Form 4
Jun 15	Jennifer E. Cook Director	Sold10b5-1 plan 2 parts	90,240	$66.63 average	$6.01M	93%	Form 4
Jun 4 – 5	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 14 parts	80,000	$67.67 average	$5.41M	1.6%	Form 4
May 21	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 5 parts	26,103	$69.44 average	$1.81M	0.5%	Form 4
May 18	Thomas Trimarchi President and CFO	Sold10b5-1 plan 2 parts	13,651	$65.08 average	888K	3.7%	Form 4
May 15	Randal W. Scott Director	Sold10b5-1 plan 4 parts	10,000	$67.15 average	671K	39%	Form 4
May 7 – 8	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 12 parts	80,000	$67.40 average	$5.39M	1.5%	Form 4
Apr 30	Maricel Apuli Chief Accounting Officer	Sold10b5-1 plan	2,000	$71.58	143K	1.5%	Form 4
Apr 9 – 10	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 8 parts	80,000	$74.61 average	$5.97M	1.5%	Form 4
Mar 12 – 13	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 10 parts	80,000	$68.76 average	$5.5M	1.5%	Form 4
Mar 10	Hannah Valantine Director	Sold10b5-1 plan	8,671	$72.00	624K	52%	Form 4
Mar 4	Andrea Ellis Director	Sold10b5-1 plan	64,921	$64.87	$4.21M	78%	Form 4
Feb 27	Hannah Valantine Director	Sold10b5-1 plan 2 parts	25,484	$67.41 average	$1.72M	76%	Form 4
Feb 26	Maricel Apuli Chief Accounting Officer	Sold10b5-1 plan	2,000	$66.00	132K	1.6%	Form 4
Feb 19	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 3 parts	28,053	$71.39 average	$2M	0.5%	Form 4
Feb 17	Maricel Apuli Chief Accounting Officer	Sold10b5-1 plan	510	$74.31	38K	0.4%	Form 4
Feb 17	Thomas Trimarchi President and CFO	Sold10b5-1 plan 2 parts	13,600	$74.72 average	$1.02M	3.9%	Form 4
Feb 17	Randal W. Scott Director	Sold10b5-1 plan 3 parts	10,000	$75.46 average	755K	39%	Form 4
Feb 10 – 11	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 12 parts	80,000	$71.86 average	$5.75M	1.5%	Form 4
Jan 8 – 9	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 14 parts	80,000	$75.54 average	$6.04M	1.4%	Form 4
Dec 15, 2025	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 2 parts	30,011	$74.64 average	$2.24M	0.5%	Form 4
Dec 8, 2025	Maricel Apuli Chief Accounting Officer	Sold10b5-1 plan	2,000	$74.26	149K	1.5%	Form 4
Dec 4, 2025 – Dec 5, 2025	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 10 parts	80,000	$73.86 average	$5.91M	1.4%	Form 4
Nov 20, 2025	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 3 parts	26,156	$65.84 average	$1.72M	0.5%	Form 4
Nov 17, 2025 – Nov 18, 2025	Andrew Lo Director	SoldNo plan 4 parts	95,599	$66.11 average	$6.32M	60%	Form 4
Nov 17, 2025	Randal W. Scott Director	Sold10b5-1 plan 2 parts	10,000	$66.65 average	666K	39%	Form 4
Nov 17, 2025	Thomas Trimarchi President and CFO	Sold10b5-1 plan 2 parts	16,934	$66.46 average	$1.13M	4.2%	Form 4
Nov 12, 2025	Hannah Valantine Director	SoldNo plan	25,484	$66.07	$1.68M	76%	Form 4
Nov 6, 2025 – Nov 7, 2025	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 12 parts	80,000	$62.29 average	$4.98M	1.4%	Form 4
Nov 6, 2025	Ronald J Daniels Director	SoldNo plan	61,031	$63.72	$3.89M	78%	Form 4
Oct 29, 2025	Frank McCormick Director	Sold10b5-1 plan 5 parts	198,359	$66.58 average	$13.2M	21%	Form 4
Oct 27, 2025	Frank McCormick Director	Sold10b5-1 plan	1,641	$65.00	107K	0.2%	Form 4
Oct 8, 2025 – Oct 9, 2025	Neil Kumar Chief Executive Officer	Sold10b5-1 plan 6 parts	80,000	$54.79 average	$4.38M	1.4%	Form 4

Oct 3010b5-1 plan
Maricel Apuli
Chief Accounting Officer · sold 2,000 at $72.85
146K
1.6% of stake
Sep 1710b5-1 plan
Neil Kumar
Chief Executive Officer · sold 10,000 at avg $69.08
691K
0.2% of stake
Aug 18 – 1910b5-1 plan
Neil Kumar
Chief Executive Officer · sold 44,980 at avg $82.86
$3.73M
0.9% of stake
Jul 3010b5-1 plan
Maricel Apuli
Chief Accounting Officer · sold 2,000 at $80.06
160K
1.5% of stake
Jul 910b5-1 plan
Andrea Ellis
Director · sold 17,167 at $84.00
$1.44M
43% of stake
Jul 910b5-1 plan
Jennifer E. Cook
Director · sold 148,589 at avg $88.54
$13.2M
95% of stake
Jun 23 – 2410b5-1 plan
Jennifer E. Cook
Director · sold 39,363 at avg $69.92
$2.75M
82% of stake
Jun 22 – 2310b5-1 plan
Hannah Valantine
Director · sold 5,004 at avg $68.25
342K
34% of stake
Jun 1510b5-1 plan
Jennifer E. Cook
Director · sold 90,240 at avg $66.63
$6.01M
93% of stake
Jun 4 – 510b5-1 plan
Neil Kumar
Chief Executive Officer · sold 80,000 at avg $67.67
$5.41M
1.6% of stake
May 2110b5-1 plan
Neil Kumar
Chief Executive Officer · sold 26,103 at avg $69.44
$1.81M
0.5% of stake
May 1810b5-1 plan
Thomas Trimarchi
President and CFO · sold 13,651 at avg $65.08
888K
3.7% of stake
May 1510b5-1 plan
Randal W. Scott
Director · sold 10,000 at avg $67.15
671K
39% of stake
May 7 – 810b5-1 plan
Neil Kumar
Chief Executive Officer · sold 80,000 at avg $67.40
$5.39M
1.5% of stake
Apr 3010b5-1 plan
Maricel Apuli
Chief Accounting Officer · sold 2,000 at $71.58
143K
1.5% of stake
Apr 9 – 1010b5-1 plan
Neil Kumar
Chief Executive Officer · sold 80,000 at avg $74.61
$5.97M
1.5% of stake
Mar 12 – 1310b5-1 plan
Neil Kumar
Chief Executive Officer · sold 80,000 at avg $68.76
$5.5M
1.5% of stake
Mar 1010b5-1 plan
Hannah Valantine
Director · sold 8,671 at $72.00
624K
52% of stake
Mar 410b5-1 plan
Andrea Ellis
Director · sold 64,921 at $64.87
$4.21M
78% of stake
Feb 2710b5-1 plan
Hannah Valantine
Director · sold 25,484 at avg $67.41
$1.72M
76% of stake
Feb 2610b5-1 plan
Maricel Apuli
Chief Accounting Officer · sold 2,000 at $66.00
132K
1.6% of stake
Feb 1910b5-1 plan
Neil Kumar
Chief Executive Officer · sold 28,053 at avg $71.39
$2M
0.5% of stake
Feb 1710b5-1 plan
Maricel Apuli
Chief Accounting Officer · sold 510 at $74.31
38K
0.4% of stake
Feb 1710b5-1 plan
Thomas Trimarchi
President and CFO · sold 13,600 at avg $74.72
$1.02M
3.9% of stake
Feb 1710b5-1 plan
Randal W. Scott
Director · sold 10,000 at avg $75.46
755K
39% of stake
Feb 10 – 1110b5-1 plan
Neil Kumar
Chief Executive Officer · sold 80,000 at avg $71.86
$5.75M
1.5% of stake
Jan 8 – 910b5-1 plan
Neil Kumar
Chief Executive Officer · sold 80,000 at avg $75.54
$6.04M
1.4% of stake
Dec 15, 202510b5-1 plan
Neil Kumar
Chief Executive Officer · sold 30,011 at avg $74.64
$2.24M
0.5% of stake
Dec 8, 202510b5-1 plan
Maricel Apuli
Chief Accounting Officer · sold 2,000 at $74.26
149K
1.5% of stake
Dec 4, 2025 – Dec 5, 202510b5-1 plan
Neil Kumar
Chief Executive Officer · sold 80,000 at avg $73.86
$5.91M
1.4% of stake
Nov 20, 202510b5-1 plan
Neil Kumar
Chief Executive Officer · sold 26,156 at avg $65.84
$1.72M
0.5% of stake
Nov 17, 2025 – Nov 18, 2025No plan
Andrew Lo
Director · sold 95,599 at avg $66.11
$6.32M
60% of stake
Nov 17, 202510b5-1 plan
Randal W. Scott
Director · sold 10,000 at avg $66.65
666K
39% of stake
Nov 17, 202510b5-1 plan
Thomas Trimarchi
President and CFO · sold 16,934 at avg $66.46
$1.13M
4.2% of stake
Nov 12, 2025No plan
Hannah Valantine
Director · sold 25,484 at $66.07
$1.68M
76% of stake
Nov 6, 2025 – Nov 7, 202510b5-1 plan
Neil Kumar
Chief Executive Officer · sold 80,000 at avg $62.29
$4.98M
1.4% of stake
Nov 6, 2025No plan
Ronald J Daniels
Director · sold 61,031 at $63.72
$3.89M
78% of stake
Oct 29, 202510b5-1 plan
Frank McCormick
Director · sold 198,359 at avg $66.58
$13.2M
21% of stake
Oct 27, 202510b5-1 plan
Frank McCormick
Director · sold 1,641 at $65.00
107K
0.2% of stake
Oct 8, 2025 – Oct 9, 202510b5-1 plan
Neil Kumar
Chief Executive Officer · sold 80,000 at avg $54.79
$4.38M
1.4% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BBIO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with BBIO

CompareIntrinsic value

KNSAKiniksa Pharmaceuticals International, plc

$96.12+3.03%71

HRMYHarmony Biosciences Holdings, Inc.

$34.42-7.04%82

ANIPAni Pharmaceuticals Inc.

$72.89+0.84%85

IONSIonis Pharmaceuticals, Inc.

$40.15-0.67%39

CORTCorcept Therapeutics Incorporated

$77.59-5.30%56

SUPNSupernus Pharmaceuticals Inc.

$28.21+0.21%44

COLLCollegium Pharmaceutical Inc.

$23.56-0.72%98

TGTXTG Therapeutics, Inc.

$61.63+1.45%57

Held by ETFs

BBIO is in 104 US ETFs. The largest of them, with BBIO's weight in each:

Spot a number that looks wrong? Check it in BBIO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BBIO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.